EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action

Thijs Kuipers iD, Renske A B Oude Nijhuis, Roos E Pouw, Albert J Bredenoord

Endoscopy · 01.12.2024 · 56 (12) · 897-905

DOI: 10.1055/a-2333-5232 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Endoscopy, erschienen am 01.12.2024. Verfasst von Thijs Kuipers und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Amsterdam UMC Location AMC, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Proton Pump Inhibitors, Esophageal pH Monitoring. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies suggested that antireflux mucosectomy (ARMS) is effective in reducing reflux symptoms and total acid exposure, although the mechanism is unknown. Our objective was to investigate the effect of ARMS on reflux parameters and its mechanism of action.

Methods

Gastroesophageal reflux disease (GERD) patients with insufficient symptom control despite a twice-daily proton pump inhibitor (PPI) underwent a piecemeal multiband mucosectomy of 50% of the circumference of the esophagogastric junction (EGJ), extending 2 cm into the cardia. The primary end point was the total number of reflux episodes during 24-hour pH-impedance studies.

Results

11 patients (8 men; median age 37 [interquartile range (IQR) 32–57] years) were treated, with one patient subsequently lost to follow-up. ARMS reduced the median (IQR) number of total reflux episodes (74 [60–82] vs. 37 [28–66]; P = 0.008) and total acid exposure time (8.7% [6.4%–12.7%] vs. 5.3% [3.5%–6.7%]; P = 0.03). Treatment reduced the median (IQR) number of transient lower esophageal sphincter relaxations (TLESRs) during a 90-minute postprandial period (4 [1–8] vs. 2 [1–4]; P = 0.03) and reflux symptom scores (3.6 [3.6–3.9] vs. 1.6 [0.7–2.7]; P = 0.005). Treatment did not increase the mean (SD) dysphagia scores (8.2 [7.3] vs. 8.5 [6.5]) or change the EGJ distensibility on impedance planimetry (4.4 [2.1] vs. 4.3 [2.2] mm2/mmHg). One delayed post-procedural bleed requiring repeat endoscopy occurred (10%); no strictures developed.

Conclusion

ARMS is an effective treatment option in PPI-refractory GERD, reducing acid exposure, reflux episodes, and symptoms. While its working mechanism could not be explained by a difference in distensibility, a reduction in TLESRs might play a role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxProton Pump InhibitorsEsophageal pH MonitoringHumansMaleMiddle AgedFemaleAdultEsophagogastric JunctionTreatment OutcomeManometryEndoscopic Mucosal ResectionElectric ImpedanceEsophageal Sphincter, Lower

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, Amsterdam UMC Location AMC, Amsterdam, Netherlands.
  • Gastroenterology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.

ORCID-Profile: Thijs Kuipers

Zitieren

APA

Kuipers, T., Oude Nijhuis, R. A. B., Pouw, R. E., & Bredenoord, A. J. (2024). Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action. Endoscopy, 56(12), 897-905. https://doi.org/10.1055/a-2333-5232

Vancouver

Kuipers T, Oude Nijhuis RAB, Pouw RE, Bredenoord AJ. Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action. Endoscopy. 2024;56(12):897-905. doi:10.1055/a-2333-5232

BibTeX
@article{Kuipers2024,
  author = {Kuipers, Thijs and Oude Nijhuis, Renske A B and Pouw, Roos E and Bredenoord, Albert J},
  title = {Antireflux mucosectomy for gastroesophageal reflux disease: efficacy and the mechanism of action},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {12},
  pages = {897--905},
  doi = {10.1055/a-2333-5232}
}
Kostenlos starten →